Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AXON vs MRNA✓SelectedUSD · MRNAAXON vs MRNA performance historyLatest closeAs of-5.16%11/20
Stock and ETF performance explorer

AXON vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+28.7%
MRNA return
+153.9%
Excess return
-125.2%
Maximum drawdown
-66.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-5.2%-2.2%-3.0%-5.1%
7D-7.7%-12.7%+5.0%-7.2%
30D-27.7%-20.7%-7.0%-27.2%
3M-52.6%+46.3%-98.9%-53.5%
6M-26.9%+305.2%-332.2%-33.4%
YTD-48.7%+561.2%-610.0%-54.5%
1Y-44.0%+772.1%-816.1%-50.6%
3Y+28.7%+147.0%-118.3%+12.2%
All+28.7%+153.9%-125.2%+12.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling